Just seeking some clarification in my thinking.....
In the latest investor webinar Bradley Glover said they are spending the next couple of months finalising a Phase 2 strategy for Azer Cel (so May/June). Not sure how long to compile the submission butallow a month (July). Lodge with FDA and because of Fast Track designation they respond in 60 days (if i am understanding correctly - Aug/Sept). So am i correct in thinking the Phase 2 for Azer Cel could be approved Oct/Nov this year? Lesley always said 2nd half for Phase 2/3 but in the interview before the last investor conference she said early 2026 for Azer Cel collating data (which i hope means they are on the trial and collecting the data from that trial).
Am i anywhere near on track with this thinking? Thanks
IMU Price at posting:
2.2¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)